Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. - Wikidata - awgldk - TriplyDB

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.

http://www.wikidata.org/entity/Q36378255

about

Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model The Notch signaling regulates CD105 expression, osteogenic differentiation and immunomodulation of human umbilical cord mesenchymal stem cells Notch Signaling in Neuroendocrine Tumors Redox Regulation in Cancer Stem Cells Cancer stem cells--important players in tumor therapy resistance Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?Regulation of ovarian cancer stem cells or tumor-initiating cells From fly wings to targeted cancer therapies: a centennial for notch signaling The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells N-acetylcysteine negatively regulates Notch3 and its malignant signaling Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin Identification of ovarian cancer driver genes by using module network integration of multi-omics data.Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.Whole exome sequence analysis of serous borderline tumors of the ovary.ABC transporters in CSCs membranes as a novel target for treating tumor relapse.DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles Notch inhibitors for cancer treatment.p53: the barrier to cancer stem cell formation.Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer Notch signaling in serous ovarian cancer.Tackling the cancer stem cells - what challenges do they pose?Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells.Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.Ovarian cancer stem cells: are they real and why are they important?Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells Targeting cancer stem cells in solid tumors by vitamin D.Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors.A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer.DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.

P2860

Q21090788-4DEB6C01-17DC-46B2-ADC1-4EB6F1E21E8F Q23922359-5850B6A2-2B17-44C0-BD49-05CEE23431F1 Q26752380-990B8078-B1E4-4846-ABF0-CC227AEAA99C Q26798198-B39B25FB-F6F3-4296-82CE-7B4A629E814E Q26823015-8770C697-C927-43E8-9BA5-0C1772D53AF9 Q26826899-6E8B929D-492F-4A0F-A85F-DC5BACD1C527 Q26853096-618E7F67-74B0-486D-92A3-A8275AE8D65F Q27004534-B32AEAF1-C515-453C-8DBE-75E832323DBC Q27008375-41D36520-86EE-4B76-B261-97E333F4CC94 Q28250934-11A81881-76B0-43F9-8FDA-22759A3EE04C Q28391353-E1D13F8B-06F3-42A3-86B2-DAC26BB1251C Q28540634-AF0D98FD-E346-45BB-8EFD-D351FDA5B61A Q30753342-35DFCE18-B2CE-488D-8997-9E9169DE0C98 Q33572252-759AB494-DB49-4228-A2BF-69751F9BAF20 Q33572313-410655CF-7FB7-436D-8BFE-2CDE9C196CDB Q33741828-61E7AD00-3FE0-4C19-B507-1336D7FF8B4F Q33851035-F59723B2-0368-4582-8C0F-A56A0D616CA1 Q33853093-100C01E2-4440-4D94-910C-A139F1FA7CBD Q33879326-9DEB1450-5B02-4C3E-B00E-81A3C2EDC2AD Q33894314-4CE63C97-5233-4074-BC5E-8D900CEB50C8 Q34022694-E3853C06-8B99-4F73-B754-7671C06ED4EF Q34227763-EFA9A3F8-BD6D-4E4C-A3B0-FD9625DF2AE6 Q34330869-CEF7AAA5-C718-4BBB-B968-208D15C8F9DF Q34406072-35668710-BC8D-44F9-BD84-DE6549EAFFC2 Q34428162-DD7993B9-DAB9-4878-B9F4-0BBE39CACE9A Q34491211-1683A36A-1EEE-45F5-A81C-C5170FF927EA Q34523263-7E7CBD32-0897-453E-A1B0-4D8C99D79F6A Q34698624-879B8666-B241-4E9E-AA56-647EB0371BE1 Q34720726-B12976E2-7019-4538-AB4C-901871CCC85B Q34820412-8401EB80-4218-4020-94AB-8630E18C26EF Q34968735-05EA1651-4F3F-463A-9752-EBF024356D96 Q35047699-8EF7F4B9-4154-4BDE-B1BC-031CD326B686 Q35080578-A0325464-4D30-46C7-95D1-DDF4B6544DC0 Q35181108-DA228EBF-0C06-494A-A16B-6940785F1476 Q35377658-13AD3E10-27E2-40CF-800B-76D1CA13D663 Q35650181-EA90779F-2197-4573-8D21-823BAA88CCC0 Q35676920-7A8A2B4D-85E3-45E8-B818-C85D6EFC9B8B Q35687072-56910B89-4D4B-4185-BE62-2981A6858EA6 Q35711333-C082BB5D-1E55-4125-86D0-91CADED2D5D8 Q35740115-802981D3-4A8C-41BE-A642-6F2824B689CC

P2860

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.

http://www.wikidata.org/entity/Q36378255

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@ast

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@en

type

label

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@ast

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@en

prefLabel

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@ast

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@en

P1433

Q36378255-5151A9A5-4D39-48ED-B10E-FAEFC560E1A1

P1476

Q36378255-DF990712-8712-4D61-84D6-92CFF2206B85

P2093

Q36378255-045BCE12-9D8F-406B-BD09-B46BD93BE5B8

Q36378255-0BBDD63D-8C37-48AD-9347-C5A860E11BD8

Q36378255-1636BCE3-E7F8-4F9C-8F39-66A5D1EAA5D3

Q36378255-25BFA6EB-C194-48AE-B145-A5AD1B0BB7F9

Q36378255-2E1E3B12-ED54-4CAD-9FFF-1C661E632C52

Q36378255-3B6FAFD4-46FA-44AB-9E21-C0ABC4D26631

Q36378255-5E73974E-4925-49A4-9E82-0AA0C12B458D

Q36378255-69BD501F-1761-45A0-8914-1FF5A3E5EEB9

Q36378255-6CB910D5-7235-445A-881C-5F1F92CD0C72

Q36378255-72B373E0-8B3D-43A6-80FF-7CD1F61EB2CC

P2860

Q36378255-00AE1531-9D32-4F00-90DA-A68467B8EAEA

Q36378255-0A795E8B-00B1-4011-99EE-955BDBA3515E

Q36378255-19754426-FE94-43F9-9BC7-7138832CA0B0

Q36378255-20940793-7831-40C5-B372-B2CE357AB02D

Q36378255-302761F2-964D-4F50-B42B-71FD9D062043

Q36378255-390F2F8A-FF92-49E2-B5F6-56DF4169B5D1

Q36378255-39A952C9-359E-40EA-A5E2-E738669DA643

Q36378255-3CE96403-7796-4357-86D6-059D0E1DECDA

Q36378255-4518F516-F1F8-4528-ACF5-D8612A577586

Q36378255-48EED530-835F-492B-9CF9-4062FCA38F93

P304

Q36378255-1846CD96-439D-4AC2-9C34-9D562917B11B

P31

Q36378255-6E7BD85C-27F0-481F-BFAB-7B187C031DDD

P356

Q36378255-D2209D16-6510-41E7-AD06-76BE9D2B3D57

P407

Q36378255-02C6CC0C-62AF-4ED4-B693-599224523392

P433

Q36378255-60451A2A-EE7C-46FE-ADB9-03FAD55E1427

P478

Q36378255-64EA42D0-CE53-46A4-A158-0B6F47A32058

P577

Q36378255-CFB162B9-2AB5-456C-8DAE-2EEC424F03DF

P5875

Q36378255-8414812E-480B-48FA-B67F-2B8B05C4E6B9

P698

Q36378255-20C5D39A-9BE5-45E8-AFB4-3AA59C86B9DE

P921

Q36378255-C2202DC8-4EE4-45E5-85B7-B001C7B90BD7

P932

Q36378255-961BF14A-D28D-4BDF-8C91-37513C0765EA

P356

PNAS.1206400109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeting Notch, a key pathway ...... es tumors to platinum therapy.

@en

P2093

Barish B Poole

http://www.w3.org/2001/XMLSchema#string

Daniela M Dinulescu

http://www.w3.org/2001/XMLSchema#string

Emily Kantoff

http://www.w3.org/2001/XMLSchema#string

Gregory A Wyant

http://www.w3.org/2001/XMLSchema#string

John Daggett

http://www.w3.org/2001/XMLSchema#string

Jon C Aster

http://www.w3.org/2001/XMLSchema#string

Julia Berkowitz

http://www.w3.org/2001/XMLSchema#string

Justin C Partridge

http://www.w3.org/2001/XMLSchema#string

Katherine W Muto

http://www.w3.org/2001/XMLSchema#string

Kathleen Hasselbatt

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

The epithelial-mesenchymal transition generates cells with properties of stem cells

Therapeutic antibody targeting of individual Notch receptors

Integrated genomic analyses of ovarian carcinoma

Stem cells, cancer, and cancer stem cells

Ovarian surface epithelium: biology, endocrinology, and pathology

Identification of selective inhibitors of cancer stem cells by high-throughput screening

Molecular definition of breast tumor heterogeneity

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary

P304

E2939-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1206400109

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231225715

http://www.w3.org/2001/XMLSchema#string

P698

23019585

http://www.w3.org/2001/XMLSchema#string

P921

P932

3491453

http://www.w3.org/2001/XMLSchema#string